Chaperone Therapeutics
Chapel Hill, US · Delaware corporation
Founders & leadership
KM
Kalpana MerchantExecutive
DT
Dennis ThieleNamed on SEC filing
MS
Maria Sippola-ThieleNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$456.6K disclosed across 1 round · 2016
▶$456.6KraisedJan 2017 · 5 investors · Other Health CareRule 506(b)
▶$456.6KraisedJan 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kalpana MerchantExecutive Officer
- Dennis ThieleExecutive Officer, Director
- Maria Sippola-ThieleExecutive Officer, Director, Promoter
- Offering amount
- $900K
- Amount sold
- $456.6K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Chaperone Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $270K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Chaperone Therapeutics raised?
- Chaperone Therapeutics has disclosed $456.6K raised across 1 round.
- Where is Chaperone Therapeutics headquartered?
- Chaperone Therapeutics is headquartered in Chapel Hill, US.
